Q3 earnings, retail inflation data, foreign fund outflow, crude oil prices and global cues will dictate market trends this ...

Currently, 100 companies have filed draft offer letters with the SEBI, with many already receiving approval or awaiting ...

There's no denying Tesla has been the centerpiece of the electric vehicle (EV) revolution to date. And rightfully so. It didn ...

Shares of Quadrant Future IPO is trading at a premium of ₹145 in the grey market, as per market observers on January 12. The ...

Business conditions look good with the new federal administration to go public, but first do your preparation. Timing is ...

Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Stay away from Diginex Limited's IPO due to declining revenue, high debt, and intense competition in the ESG market. Read ...

Energy equipment and services provider Flowco launched the year’s first major IPO, planning to raise $392 million and list in ...

Southeast Asia’s equity capital markets reached a grim milestone in 2024, as IPO activity plunged to its lowest in nearly a ...

Metsera files for IPO, developing GLP-1 drug MET-097i and other obesity treatments to compete with Eli Lilly and Novo Nordisk ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

Metsera, founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners, revealed a net ...